A Smart Nanomedicine Unleashes a Dual Assault of Glucose Starvation and Cuproptosis to Supercharge αPD‐L1 Therapy
Abstract Combination therapy has become a promising strategy for promoting the outcomes of anti‐programmed death ligand‐1 (αPD‐L1) therapy in lung cancer. Among all, emerging strategies targeting cancer metabolism have shown great potency in treating cancers with immunotherapy. Here, alteration in g...
Saved in:
| Main Authors: | Yiming Xu, Yuan Wu, Xinjie Zheng, Dongxue Wang, Hangqi Ni, Weiyu Chen, Kai Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202411378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy
by: Jiaxin Li, et al.
Published: (2025-10-01) -
Sonodynamic biomimetic-nanomedicine fight cancers
by: Anni Zhang, et al.
Published: (2025-07-01) -
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies
by: Zhan Zhang, et al.
Published: (2025-10-01) -
Novel Pt@PCN-Cu-induced cuproptosis amplifies αPD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation
by: Pengyu Wang, et al.
Published: (2025-05-01) -
Antiviral nanomedicine: Advantages, mechanisms and advanced therapies
by: Yicheng Pu, et al.
Published: (2025-10-01)